Estimation of plasma and urinary catecholamines in Guillain-Barre syndrome.

Publisher Website
Google Scholar
Abstract
Serial estimation of plasma norepinephrine (PNE), 24 h urinary vanilmandelic acid (VMA) and plasma cortisol was made in 25 adult patients of Guillain-Barre syndrome. Healthy adult age and sex matched volunteers served as controls. The mean level of PNE, VMA and plasma cortisol in controls was 1.07 .+-. 0.50 ng/ml, 2.81 .+-. 1.18 mg/24 h and 12.9 .+-. 3.10 .mu.g/100 ml, respectively. In cases of Guillain-Barre syndrome with autonomic dysfunction the mean level of PNE, VMA and plasma cortisol was 3.34 .+-. 2.47 ng/ml, 7.98 .+-. 5.71 mg/24 h and 27.25 .+-. 4.94 .mu.g/100 ml on the day of admission while in cases of Guillain-Barre syndrome without autonomic dysfunction it was 1.09 .+-. 0.32 ng/ml, 3.04 .+-. 2.22 mg/24 h and 11.8 .+-. 4.2 .mu.g/100 ml, respectively. An increase in circulating PNE, VMA and plasma cortisol was demonstrated in patients of Guillan-Barre syndrome with autonomic dysfunction presenting as hypertension and tachycardia. The maximum rise of 284% (PNE) and 253% (VMA) occurred at the height of paralysis. The elevated levels fell to near control values at the time of significant recovery, and glucose tolerance tests improved. Apparently, increased levels of catecholamines and cortisol contributed to the development of dysautonomia as these levels were within normal limits in patients of Guillain-Barre syndrome without autonomic dysfunction.

This publication has 1 reference indexed in Scilit: